New patent for Abbvie Inc drug MAVYRET
December 6, 2022 Comments Off on New patent for Abbvie Inc drug MAVYRET Posted in: Patent Added Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are nine patents…
The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.
New patent for Abbvie Inc drug MAVYRET
Comments Off on New patent for Abbvie Inc drug MAVYRET Posted in: Patent Added Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are nine patents…
The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.
Comments are closed.